Authors: SMITH MB WOLINSKY J

Citation: Mb. Smith et J. Wolinsky, REDUCTION OF THIOLS WITH LIALD4 - A MECHANISTIC STUDY, Perkin transactions. 2, (6), 1998, pp. 1431-1433

Authors: EBERS GC RICE G LESAUX J PATY D OGER J LI DKB BEALL S DEVONSHIRE V HASHIMOTO S HOOGE J KASTRUKOFF L KRIEGER C MEZEI M SELAND P VOROBEYCHI G MORRISON W NELSON J FREEDMAN MS CHRISIE S NELSON R RABINOVITCH H FREEDMAN C HARTUNG HP RIECKMANN P ARCHELOS J JUNG S WEILBACH F FLACHENECKE P SAUER J HOMMES O JONGEN P BROUWER S MCLEOD J POLLARD J NG R SANDBERGWOLLHEIM M KALLEN K NILSSON P EKBERG R LUNDGREN A JADBACK G WIKSTROM J MULTANEN J VALJAKKA M CARTON H LISSOIR F DECLERQ I VIEREN M PEETERS E DUBOIS B DEKEERSMAEKER E VANHERLE A HUGHES RAC SHARRACK B SOUDAIN S PANELIUS M ERALINNA J SOILUHANNINEN M MURTO S MEDAER R BROECKX J VANROOSE E BOGAERS A BLUMHARDT LD EDWARDS S LIU C ORPE V BARNES D SCHWARTZ M STOY N HARRAGHY C BERTELSMANN F UITDEHAAG B NASSERI K CHOFFLON M ROTH S KAPPOS L HUBER S BELLAICHE Y SENN C KING J JUBERT J WHITTEN S NEWSOMDAVIS JM PALACE J LEE M EVANGELOU N PINTO A CAVEY A SINDIC CJM MONTEYNE P VEROUGSTRAETE D VANDOORN PA MOLL W VISSER L WILLEMS M MARTINA I BULJEVAC D LOMAN L BATES D PANDIT D IRVING J RHODES B RIDDEHOUGH A ZHAO GJ WANG X CHENG Y AMMOURY N DUPONT F GALAZKA A HYDE R OLSON M PERNIN MO ABDULAHAD AK HOMMES O NOSEWORTHY J BORDEN E OBRIEN P WOLINSKY J

Citation: Gc. Ebers et al., RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED STUDY OF INTERFERON BETA-1A IN RELAPSING REMITTING MULTIPLE-SCLEROSIS/, Lancet, 352(9139), 1998, pp. 1498-1504

Authors: LUBLIN FD REINGOLD SC CLANET M COOKFAIR D EBERS G GOODKIN D HARTUNG HP LISAK R MCDONALD WI MCFARLAND H NOSEWORTHY J PANITCH H POLMAN C REDER A RUDGE P SIBLEY W WHITAKER J WOLINSKY J

Citation: Fd. Lublin et al., GUIDELINES FOR CLINICAL-TRIALS OF NEW THERAPEUTIC AGENTS IN MULTIPLE-SCLEROSIS - RELATIONS BETWEEN STUDY INVESTIGATORS, ADVISERS, AND SPONSORS, Neurology, 48(3), 1997, pp. 572-574

Authors: MARSHALL GD HENNINGER E KHAN M WOLINSKY J BROD S SRIRAM S

Citation: Gd. Marshall et al., INTERFERON-BETA-1B TREATMENT OF RELAPSING-REMITTING MULTIPLE-SCLEROSIS DECREASES CD3-MEDIATED TUMOR-NECROSIS-FACTOR-ALPHA AND INCREASES CD3-MEDIATED INTERLEUKIN-6 PRODUCTION EX-VIVO, Neurology, 46(2), 1996, pp. 1075-1075

Authors: BROD SA KHAN M BRIGHT J SRIRAM S MARSHELL GD WOLINSKY J

Citation: Sa. Brod et al., DECREASED CD3-MEDIATED INTERFERON-GAMMA PRODUCTION IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS, Neurology, 45(4), 1995, pp. 164-164

Authors: SYNDULKO K TOURTELLOTTE WW CONRAD AJ IZQUIERDO G BELENDUK G KASPER B KLATZMAN D MIETLOWSKI W SOLCH S FRANKLIN G BURKS J NELSON L WANGAARD C MCFARLAND H GOODMAN A MCFARLIN D KREBS H MALONI H DEBRONOZO J SCHEINBERG L TRAUGOTT U AISEN M ROBBINS K SIBLEY W LAGUNA J LAGUNA J TROTTER J CLIFORD D SMITH L MCINNIS J ARNASON B ROOS R REDER A ANTEL J AGUIS M MARTIA R HURWITZ B GREENBURG S FREDANE L HERBSTREITH R HURWITZ J JOHNSON K PANITCH H KOSKI CL FISHMAN P HALEY S PETAJAN J BRAY P ROSE J THURMAN D GALSTER W ELLISON G MYERS L NEWTON L WOLINSKY J SEARS ES NATH A WEISBRODT C KASTRUKOFF LF OGER JJ PATY D BAUMHEFNER RW

Citation: K. Syndulko et al., TRANS-BLOOD-BRAIN-BARRIER ALBUMIN LEAKAGE AND COMPARISONS OF INTRATHECAL IGG SYNTHESIS CALCULATIONS IN MULTIPLE-SCLEROSIS PATIENTS, Journal of neuroimmunology, 46(1-2), 1993, pp. 185-192